Regenics vs bmiMD: Compounded GLP-1 pricing and program differences
Regenics vs bmiMD compares two telehealth options for compounded GLP-1 or GLP-1/GIP therapy. Quick verdict: Regenics is best for straightforward entry with both semaglutide and tirzepatide at promotional first-month prices, while bmiMD is best for lower long-term monthly equivalents if you commit to multi-month plans.
Explore Regenics pricing and options
How they differ in drugs offered and clinical model
Regenics offers compounded semaglutide and compounded tirzepatide plus an optional Sermorelin peptide therapy, with care described as nurse-practitioner-led and prescriptions reviewed by a licensed clinician before prescribing. bmiMD focuses on compounded tirzepatide only, with clinician review also required. Both note that treatment is available only when a licensed clinician determines it is medically appropriate and that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality.
Key difference 1: Pricing structure and promotional terms
Regenics advertises promotional first-month pricing: semaglutide $139 first month (renews $199/mo) and tirzepatide $189 first month (renews $279/mo). The source states promotional pricing applies to the first month only and that monthly cost increases on renewal. bmiMD lists tiered monthly equivalents tied to term commitments: $179 month-to-month, $159/mo for three-month plan, $149/mo for six-month plan, and $139/mo for a 12-month plan, with the lowest price requiring a 12-month commitment. bmiMD highlights lower long-term monthly equivalent pricing but notes the lowest price requires a commitment and that total prepaid charge should be confirmed.
Key difference 2: Drug selection and add-ons
Regenics supports both compounded semaglutide and compounded tirzepatide and also offers a Sermorelin peptide therapy option priced in the source at $399 for a 15mg injectable peptide. bmiMD focuses exclusively on compounded tirzepatide in the captured evidence. If access to semaglutide or a secondary peptide like Sermorelin matters, Regenics is the only provider in these sources that lists both.
Key difference 3: Pricing commitments, shipping, and clinician access
Both providers offer free shipping with medication compounded in the USA or free subscription shipping. Regenics notes free shipping with medication compounded in the USA and a LegitScript certified pharmacy network. bmiMD advertises free shipping on every subscription order and 24/7 clinician access. bmiMD emphasizes online refills and delivery and a 100% Risk Free refund if not eligible for the program, as stated in the captured content. Regenics notes no insurance required and that plans are FSA/HSA eligible.
Comparison table
| Criterion | Regenics | bmiMD |
|---|---|---|
| Drugs offered | Compounded semaglutide and compounded tirzepatide, plus Sermorelin peptide | Compounded tirzepatide only (captured evidence) |
| Promotional/term pricing | Semaglutide $139 first month (renews $199/mo); tirzepatide $189 first month (renews $279/mo) | Tiered plans: $179/mo 1 month, $159/mo 3 month, $149/mo 6 month, $139/mo 12 month |
| Shipping | Free shipping; compounded in the USA | Free subscription shipping on every order |
| Clinical access | Licensed nurse practitioners oversee prescriptions; clinician review required | 24/7 clinician access; clinician review required |
| Regulatory note | Compounded medications not FDA-approved as finished products | Compounded medications not FDA-approved as finished products |
Safety, regulatory, and payment notes
Both sources explicitly state that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. Regenics notes its pharmacy network is LegitScript certified and that no insurance is required to start treatment; plans are FSA/HSA eligible. bmiMD highlights that the lowest monthly price requires a 12-month commitment and that total prepaid charge should be confirmed before enrolling. Both indicate treatment is subject to clinician review and medical appropriateness.
How to choose between Regenics and bmiMD
Use these supplied facts to decide. Regenics lists both compounded semaglutide and tirzepatide with nurse-practitioner-led care and promotional first-month prices, plus a Sermorelin peptide option. bmiMD centers on compounded tirzepatide with multi-month pricing that lowers the monthly equivalent if you commit to longer plans and advertises 24/7 clinician access and online refills. Both require a licensed clinician to determine appropriateness and both involve compounded medications that are not FDA-approved finished products.
Choose Regenics if…
you want access to both compounded semaglutide and compounded tirzepatide, value a nurse-practitioner-led model, want a Sermorelin peptide option, or prefer a straightforward cash-pay entry with promotional first-month pricing and FSA/HSA eligibility.
Choose bmiMD if…
you are focused on compounded tirzepatide and want lower long-term monthly equivalents through 3, 6, or 12 month plans, prefer online refills and delivery with free subscription shipping, and are comfortable confirming total prepaid charges and term commitments before enrolling.
Review bmiMD enrollment details
Primary keyword: Regenics vs bmiMD
Ready to Compare Telehealth Providers?
Explore leading providers — physician-supervised, all-inclusive pricing, and free home delivery.
Compare All Providers →